Anton Melnyk

1.2k total citations
18 papers, 677 citations indexed

About

Anton Melnyk is a scholar working on Electrical and Electronic Engineering, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Anton Melnyk has authored 18 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Electrical and Electronic Engineering, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Anton Melnyk's work include Conducting polymers and applications (4 papers), Diverse Scientific Research in Ukraine (3 papers) and Organic Electronics and Photovoltaics (3 papers). Anton Melnyk is often cited by papers focused on Conducting polymers and applications (4 papers), Diverse Scientific Research in Ukraine (3 papers) and Organic Electronics and Photovoltaics (3 papers). Anton Melnyk collaborates with scholars based in United States, Germany and Ukraine. Anton Melnyk's co-authors include Denis Andrienko, Ramaswamy Govindan, Constantin T. Yiannoutsos, Craig H. Reynolds, Cynthia S. Johnson, Sreenivasa Nattam, Angela White, Rafat Ansari, Donald Richards and Ronald C. McGarry and has published in prestigious journals such as Journal of Clinical Oncology, Energy & Environmental Science and The Journal of Physical Chemistry B.

In The Last Decade

Anton Melnyk

14 papers receiving 670 citations

Peers

Anton Melnyk
Eduardo Aluicio‐Sarduy United States
Shinichi Morita Japan
Raquel De Souza Canada
Jinlu Shan China
Shaoxiong Wu China
Ryuji Matsumoto Japan
Jim Hagekyriakou Australia
Yukihide Ota Japan
John Pedersen Canada
Eduardo Aluicio‐Sarduy United States
Anton Melnyk
Citations per year, relative to Anton Melnyk Anton Melnyk (= 1×) peers Eduardo Aluicio‐Sarduy

Countries citing papers authored by Anton Melnyk

Since Specialization
Citations

This map shows the geographic impact of Anton Melnyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Melnyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Melnyk more than expected).

Fields of papers citing papers by Anton Melnyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Melnyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Melnyk. The network helps show where Anton Melnyk may publish in the future.

Co-authorship network of co-authors of Anton Melnyk

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Melnyk. A scholar is included among the top collaborators of Anton Melnyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Melnyk. Anton Melnyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Secord, Angeles Alvarez, Michael J. Sundborg, Destin Black, et al.. (2025). A phase 3, open-label, randomized study of rinatabart sesutecan (Rina-S) vs investigator’s choice (IC) of chemotherapy in patients with platinum-resistant ovarian cancer (PROC).. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
2.
3.
4.
5.
Melnyk, Anton, et al.. (2020). Solid-State Electron Affinity Analysis of Amorphous Fluorinated Polymer Electret. The Journal of Physical Chemistry B. 124(46). 10507–10513. 15 indexed citations
6.
Schott, Sam, Vincent Lemaur, Anton Melnyk, et al.. (2019). Polaron spin dynamics in high-mobility polymeric semiconductors. Nature Physics. 15(8). 814–822. 52 indexed citations
7.
Jones, Vicky, Kristi McIntyre, Devchand Paul, et al.. (2019). Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study. The Oncologist. 24(9). 1153–1158. 15 indexed citations
8.
9.
Greco, Cristina, Anton Melnyk, Kurt Kremer, Denis Andrienko, & Kostas Ch. Daoulas. (2019). Generic Model for Lamellar Self-Assembly in Conjugated Polymers: Linking Mesoscopic Morphology and Charge Transport in P3HT. Macromolecules. 52(3). 968–981. 42 indexed citations
10.
Jhaveri, Komal, Dejan Juric, Cristina Saura, et al.. (2018). Abstract CT046: A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA-mutated locally advanced or metastatic solid tumors. Cancer Research. 78(13_Supplement). CT046–CT046. 3 indexed citations
11.
Melnyk, Anton, Matthias J. N. Junk, Michael D. McGehee, et al.. (2017). Macroscopic Structural Compositions of π-Conjugated Polymers: Combined Insights from Solid-State NMR and Molecular Dynamics Simulations. The Journal of Physical Chemistry Letters. 8(17). 4155–4160. 33 indexed citations
12.
Etzold, Fabian, Ian A. Howard, Anton Melnyk, et al.. (2015). Sub-ns triplet state formation by non-geminate recombination in PSBTBT:PC70BM and PCPDTBT:PC60BM organic solar cells. Energy & Environmental Science. 8(5). 1511–1522. 64 indexed citations
13.
Cohen, Roger B., Daniel Morgensztern, William Walsh, et al.. (2015). First interim exploratory analysis of immune response in patients with advanced non-small cell lung cancer receiving viagenpumatucel-l (HS-110) in combination with low-dose cyclophosphamide in an ongoing phase II trial.. Journal of Clinical Oncology. 33(15_suppl). 3077–3077. 1 indexed citations
14.
Quoix, Élisabeth, Lecia V. Sequist, John Nemunaitis, et al.. (2014). TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). O12–O12. 4 indexed citations
15.
Galsky, Matthew D., Noah M. Hahn, Thomas Powles, et al.. (2012). Gemcitabine, Cisplatin, and Sunitinib for Metastatic Urothelial Carcinoma and as Preoperative Therapy for Muscle-Invasive Bladder Cancer. Clinical Genitourinary Cancer. 11(2). 175–181. 69 indexed citations
16.
Galsky, Matt D., Beth A. Hellerstedt, Mark Allen O’Rourke, et al.. (2012). Phase II study of gemcitabine, cisplatin, and sunitinib (S) in patients with advanced urothelial carcinoma (UC).. Journal of Clinical Oncology. 30(5_suppl). 282–282. 9 indexed citations
17.
Hanna, Nasser H., Marcus A. Neubauer, Constantin T. Yiannoutsos, et al.. (2008). Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology. Journal of Clinical Oncology. 26(35). 5755–5760. 341 indexed citations
18.
Melnyk, Anton. (1995). Adult Hemolytic-Uremic Syndrome. Archives of Internal Medicine. 155(19). 2077–2077. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo Aluicio‐Sarduy Breakdown of academic impact, for papers by Shinichi Morita Breakdown of academic impact, for papers by Raquel De Souza Breakdown of academic impact, for papers by Jinlu Shan Breakdown of academic impact, for papers by Shaoxiong Wu Breakdown of academic impact, for papers by Ryuji Matsumoto Breakdown of academic impact, for papers by Jim Hagekyriakou Breakdown of academic impact, for papers by Yukihide Ota Breakdown of academic impact, for papers by John Pedersen
Rankless by CCL
2026